Krause Hans-Juergen,Fraunhofer Wolfgang,Bartl Annika,Kaleta Katharina,Tschoepe Markus
申请号：
NZ70970408
公开号：
NZ709704A
申请日:
2008.11.28
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
The use of an aqueous pharmaceutical formulation for the treatment of autoimmune disease, an intestinal disorder, a spondylarthropathy or a skin disorder. The formulation comprises water, at least 50 mg/ml adalimumab and has a conductivity of less than 2.5-0.5 mS/cm.
